Senores Pharmaceuticals Limited held an earnings conference call on May 16, 2025, to discuss the audited financial results for the quarter and financial year ended March 31, 2025.
The conference call included participation from several analysts, institutional investors, funds, and other investors.
Senores Pharmaceuticals was represented by Mr. Sanjay Majmudar (Chairman), Mr. Swapnil Shah (Managing Director), and Mr. Deval Shah (Whole Time Director and CFO).
The audio recording of the earnings conference call is available on the company's website at https://senorespharma.com/investor-meet/.
The company confirms that no Unpublished Price Sensitive Information (UPSI) was shared or discussed during the call.